effect of Agni( digestive capacity) in treatment of vyanga( melasma)
Phase 3
- Conditions
- Health Condition 1: L814- Other melanin hyperpigmentation
- Registration Number
- CTRI/2023/02/049922
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients having following signs and symptoms- Mandal (circular lesions or macular lesions with well defied scalloped margins), Shyava(Brown coloured hyperpigmentation), Niruja (no pain in the lesion)
2)Patients willing and able to participate in the trial for 60 days
Exclusion Criteria
1)Patients with skin allergies and other skin diseases.
2)Patients who are on different medications
3)Patients having diabetes, hypertension, cardiac diseases and suffering from any other severe diseases
4)Pregnancy and patients taking hormonal therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)Reduction in the severity score of melasma which will be assessed through modified MASI( Melasma Area Severity Index ) And improved skin color on fair and lovely color grading scale, before initiation and after completion of the treatment.Timepoint: 1)90 days
- Secondary Outcome Measures
Name Time Method 1)Improved Agnibala which will be assessed with a validated Agni Assessment tool, before initiation and after completion of the treatment.Timepoint: 90 days